Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2021 · 10-Q
Revenue$5.82M$5.82M+35.2% vs Q3 2020 Net Income-$2.05M-$2.05MN/M vs Q3 2020 EPS Diluted-$0.27-$0.27N/M vs Q3 2020 Gross Profit$5,306,331+37.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,434,273N/M Free Cash Flowderived-$1,438,984N/M Margins · derivedGross margin91.1%+1.5 pt vs Q3 2020
Operating margin-31.8%−1.5 pt vs Q3 2020
Net margin-35.2%−7.1 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end